Male fertility and strategies for fertility preservation following childhood cancer treatment

Endocrine Development

Volumn 15, Issue , 2009, Pages 101-134

  Mitchell, R T ^a   Saunders, P T K ^a   Sharpe, R M ^a   Kelnar, C J H ^b   Wallace, W H B ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; BLEOMYCIN; BUSULFAN; CARMUSTINE; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DOXORUBICIN; GONADORELIN AGONIST; IFOSFAMIDE; LOMUSTINE; MELPHALAN; PREDNISOLONE; PROCARBAZINE; SEX HORMONE; VINBLASTINE; VINCRISTINE; CYTOTOXIN;

ADULTHOOD; AZOOSPERMIA; CANCER THERAPY; CELL FUNCTION; CELL LINEAGE; CHILD DEVELOPMENT; CHILDHOOD CANCER; CLINICAL ASSESSMENT; CRYOPRESERVATION; DRUG MECHANISM; DRUG MEGADOSE; FETUS; FOLLOW UP; GERM CELL; GONAD DEVELOPMENT; GONAD DYSFUNCTION; GONAD FUNCTION; HODGKIN DISEASE; HUMAN; HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IN VITRO STUDY; INTRACYTOPLASMIC SPERM INJECTION; LEYDIG CELL; MALE GENITAL SYSTEM; MALE INFERTILITY; MARMOSET; NONHUMAN; PRIORITY JOURNAL; PUBERTY; RADIATION DOSE; RADIATION INJURY; REVIEW; RISK FACTOR; SEMINIFEROUS TUBULE EPITHELIUM; SPERM PRESERVATION; SPERMATOGENESIS; STEM CELL TRANSPLANTATION; SURVIVOR; TESTIS DEVELOPMENT; THERAPY EFFECT; XENOGRAFT; ADULT; ANIMAL; BIOLOGICAL MODEL; CHILD; DRUG EFFECT; FERTILITY; GONAD; GROWTH, DEVELOPMENT AND AGING; MALE; METHODOLOGY; NEOPLASM; PHYSIOLOGY; PRENATAL DEVELOPMENT; PRESERVATION; RADIATION EXPOSURE; REPRODUCTION; SEXUAL MATURATION; SKULL IRRADIATION;

ADULT; ANIMALS; CHILD; CRANIAL IRRADIATION; CYTOTOXINS; FERTILITY; GONADS; HUMANS; INFERTILITY, MALE; MALE; MODELS, BIOLOGICAL; NEOPLASMS; PRESERVATION, BIOLOGICAL; REPRODUCTION; SEXUAL MATURATION;

EID: 66149109598     PISSN: 14217082     EISSN: 16622979     Source Type: Book Series    
DOI: 10.1159/000207612     Document Type: Review

References (100)

1. Ande rson RA, Sharpe RM: Regulation of inhibin production in the human male and its clinical applications. Int J Androl 2000;23:136-144.
2. Anderson RA, Fulton N, Cowan G, Coutts S, Saunders PT: Conserved and divergent patterns of expression of DAZL, VASA and OCT4 in the germ cells of the human fetal ovary and testis. BMC Dev Biol 2007;7:136.
3. Gaskell TL, Esnal A, Robinson LL, Anderson RA, Saunders PT: Immunohistochemical profiling of germ cells within the human fetal testis: identification of three subpopulations. Biol Reprod 2004; 71:2012-2021.
4. Pauls K, Schorle H, Jeske W, et al: Spatial expression of germ cell markers during maturation of human fetal male gonads: an immunohistochem-ical study. Hum Reprod 2006;21:397-404.
5. Castrillon DH, Quade BJ, Wang T Y, Quigley C, Crum CP: The human VASA gene is specifically expressed in the germ cell lineage. Proc Natl Acad Sci USA 2000;97:9585-9590.
6. Mann DR, Fraser HM: The neonatal period: a critical interval in male primate development. J Endocrinol 1996;149:191-197.
7. Wu FC, Butler GE, Kelnar CJ, Huhtaniemi I, Veldhuis JD: Ontogeny of pulsatile gonadotropin releasing hormone secretion from midchildhood, through puberty, to adulthood in the human male: a study using deconvolution analysis and an ultrasensitive immunofluorometric assay. J Clin Endocrinol Metab 1996;81:1798-1805.
8. Chemes HE: Infancy is not a quiescent period of testicular development. Int J Androl 2001;24:2-7.
9. Kelnar CJ, McKinnell C, Walker M, et al: Testicular changes during infantile 'quiescence' in the marmoset and their gonadotrophin dependence: a model for investigating susceptibility of the prepubertal human testis to cancer therapy? Hum Reprod 2002;17:1367-1378.
10. Berensztein EB, Sciara MI, Rivarola MA, Belgorosky A: Apoptosis and proliferation of human testicular somatic and germ cells during prepuberty: high rate of testicular growth in newborns mediated by decreased apoptosis. J Clin Endocrinol Metab 2002;87:5113-5118.
11. Ferrara D, Hallmark N, Scott H, et al: Acute and long-term effects of in utero exposure of rats to di(n-butyl) phthalate on testicular germ cell development and proliferation. Endocrinology 2006;147:5352-5362.
12. Jahnukainen K, Ehmcke J, Soder O, Schlatt S: Clinical potential and putative risks of fertility preservation in children utilizing gonadal tissue or germline stem cells. Pediatr Res 2006;59:40R- 47R.
13. van der Meer Y, Huiskamp R, Davids JA, van der Tweel I, de Rooij DG: The sensitivity to X rays of mouse spermatogonia that are committed to differentiate and of differentiating spermatogonia. Radiat Res 1992;130:296-302.
14. Sharpe. RM: Regulation of Spermatogenesis; in Knobil E, Neill JD (eds): The Physiology of Reproduction. New York, Raven Press, 1994, pp 1363-1434.
15. Clermont Y: The cycle of the seminiferous epithelium in man. Am J Anat 1963;112:35-51.
16. Millar MR, Sharpe RM, Weinbauer GF, Fraser HM, Saunders PT: Marmoset spermatogenesis: organizational similarities to the human. Int J Androl 2000;23:266-277.
17. Thomson AB, Campbell AJ, Irvine DC, Anderson RA, Kelnar CJ, Wallace WH: Semen quality and spermatozoal DNA integrity in survivors of childhood cancer: a case-control study. Lancet 2002;360:361-367.
18. Wallace WH, Anderson RA, Irvine DS: Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol 2005;6:209-218.
19. Thomson AB, Critchley HO, Kelnar CJ, Wallace WH: Late reproductive sequelae following treatment of childhood cancer and options for fertility preservation. Best Pract Res Clin Endocrinol Metab 2002;16:311-334.
20. Wallace WH, Thomson AB: Preservation of fertility in children treated for cancer. Arch Dis Child 2003;88:493-496.
21. Papadakis V, Vlachopapadopoulou E, Van Syckle K, et al: Gonadal function in young patients successfully treated for Hodgkin disease. Med Pedi-atr Oncol 1999;32:366-372.
22. Clifton DK, Bremner WJ: The effect of testicular X-irradiation on spermatogenesis in man. A comparison with the mouse. J Androl 1983;4:387- 392.
23. Rowley MJ, Leach DR, Warner GA, Heller CG: Effect of graded doses of ionizing radiation on the human testis. Radiat Res 1974;59:665-678.
24. Petersen PM, Giwercman A, Daugaard G, et al: Effect of graded testicular doses of radiotherapy in patients treated for carcinoma-in-situ in the testis. J Clin Oncol 2002;20:1537-1543.
25. Howell SJ, Shalet SM: Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr 2005;34:12-17.
26. Ogilvy-Stuart AL, Clark DJ, Wallace WH, et al: Endocrine deficit after fractionated total body irradiation. Arch Dis Child 1992;67:1107-1110.
27. Socie G, Salooja N, Cohen A, et al: Nonmalignant late effects after allogeneic stem cell transplantation. Blood 2003;101:3373-3385.
28. Wallace WH, Shalet SM, Lendon M, MorrisJones PH: Male fertility in long-term survivors of childhood acute lymphoblastic leukaemia. Int J Androl 1991;14:312-319.
29. Wallace WH, Shalet SM, Crowne EC, Morris-Jones PH, Gattamaneni HR, Price DA: Gonadal dysfunction due to cis-platinum. Med Pediatr Oncol 1989;17:409-413.
30. Meistrich ML, Wilson G, Brown BW, da Cunha MF, Lipshultz LI: Impact of cyclophosphamide on long-term reduction in sperm count in men treated with combination chemotherapy for Ewing and soft tissue sarcomas. Cancer 1992;70: 2703-2712.
31. Pont J, Albrecht W: Fertility after chemotherapy for testicular germ cell cancer. Fertil Steril 1997; 68:1-5.
32. Schrader M, Muller M, Straub B, Miller K: The impact of chemotherapy on male fertility: a survey of the biologic basis and clinical aspects. Reprod Toxicol 2001;15:611-617.
33. Shuttlesworth GA, de Rooij DG, Huhtaniemi I, et al: Enhancement of A spermatogonial proliferation and differentiation in irradiated rats by gonadotropin-releasing hormone antagonist administration. Endocrinology 2000;141:37-49.
34. Porter KL, Shetty G, Meistrich ML: Testicular edema is associated with spermatogonial arrest in irradiated rats. Endocrinology 2006;147:1297- 1305.
35. Shetty G, Meistrich ML: Hormonal approaches to preservation and restoration of male fertility after cancer treatment. J Natl Cancer Inst Monogr 2005;34:36-39.
36. Jahnukainen K, Ehmcke J, Nurmio M, Schlatt S: Irradiation causes acute and long-term spermatogonial depletion in cultured and xenotransplanted testicular tissue from juvenile nonhuman primates. Endocrinology 2007;148:5541-5548.
37. van Alphen MM, van de Kant HJ, de Rooij DG: Depletion of the spermatogonia from the seminiferous epithelium of the rhesus monkey after X irradiation. Radiat Res 1988;113:473-486.
38. van Alphen MM, van de Kant HJ, de Rooij DG: Repopulation of the seminiferous epithelium of the rhesus monkey after X irradiation. Radiat Res 1988;113:487-500.
39. de Rooij DG, van de Kant HJ, Dol R, et al: Long-term effects of irradiation before adulthood on reproductive function in the male rhesus monkey. Biol Reprod 2002;66:486-494.
40. Darzy KH, Shalet SM: Hypopituitarism after cranial irradiation. J Endocrinol Invest 2005; 28(suppl):78-87.
41. Rappaport R, Brauner R, Czernichow P, et al: Effect of hypothalamic and pituitary irradiation on pubertal development in children with cranial tumors. J Clin Endocrinol Metab 1982;54:1164- 1168.
42. Constine LS, Woolf PD, Cann D, et al: Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med 1993;328:87-94.
43. Ogilvy-Stuart AL, Stirling H F, Kelnar CJ, et al: Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormone. Clin Endocrinol 1997;46:571-578.
44. Rueffer U, Breuer K, Josting A, et al: Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment. Ann Oncol 2001;12:1307- 1311.
45. Petersen PM, Giwercman A, Skakkebaek NE, Rorth M: Gonadal function in men with testicular cancer. Semin Oncol 1998;25:224-233.
46. van der Kaaij MA, Heutte N, Le Stang N, et al: Gonadal function in males after chemotherapy for early-stage Hodgkin's lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 2007;25:2825-2832.
47. Viviani S, Santoro A, Ragni G, Bonfante V, Bestetti O, Bonadonna G: Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD. Eur J Cancer Clin Oncol 1985;21:601-605.
48. Hovav Y, Dan-Goor M, Yaffe H, Almagor M: Electroejaculation before chemotherapy in adolescents and young men with cancer. Fertil Steril 2001;75:811-813.
49. Schover LR, Brey K, Lichtin A, Lipshultz LI, Jeha S: Oncologists' attitudes and practices regarding banking sperm before cancer treatment. J Clin Oncol 2002;20:1890-1897.
50. Schover LR, Brey K, Lichtin A, Lipshultz LI, Jeha S: Knowledge and experience regarding cancer, infertility, and sperm banking in younger male survivors. J Clin Oncol 2002;20:1880-1889.
51. Edge B, Holmes D, Makin G: Sperm banking in adolescent cancer patients. Arch Dis Child 2006; 91:149-152.
52. Blackhall FH, Atkinson AD, Maaya MB, et al: Semen cryopreservation, utilisation and reproductive outcome in men treated for Hodgkin's disease. Br J Cancer 2002;87:381-384.
53. Kurdoglu B, Wilson G, Parchuri N, Ye WS, Meis-trich ML: Protection from radiation-induced damage to spermatogenesis by hormone treatment. Radiat Res 1994;139:97-102.
54. Parchuri N, Wilson G, Meistrich ML: Protection by gonadal steroid hormones against procarbazine-induced damage to spermatogenic function in LBNF1 hybrid rats. J Androl 1993;14:257-266.
55. Ward JA, Robinson J, Furr BJ, Shalet SM, Morris ID: Protection of spermatogenesis in rats from the cytotoxic procarbazine by the depot formulation of Zoladex, a gonadotropin-releasing hormone agonist. Cancer Res 1990;50:568-574.
56. Kangasniemi M, Wilson G, Parchuri N, Huhtani-emi I, Meistrich ML: Rapid protection of rat sper-matogenic stem cells against procarbazine by treatment with a gonadotropin-releasing hormone antagonist (Nal-Glu) and an antiandrogen (flutamide). Endocrinology 1995;136:2881-2888.
57. Meistrich ML, Kangasniemi M: Hormone treatment after irradiation stimulates recovery of rat spermatogenesis from surviving spermatogonia. J Androl 1997;18:80-87.
58. Meistrich ML, Wilson G, Huhtaniemi I: Hormonal treatment after cytotoxic therapy stimulates recovery of spermatogenesis. Cancer Res 1999;59:3557-3560.
59. Crawford BA, Spaliviero JA, Simpson JM, Handelsman DJ: Testing the gonadal regression-cytoprotection hypothesis. Cancer Res 1998;58: 5105-5109.
60. Meistrich ML, Wilson G, Kangasniemi M, Huhtaniemi I: Mechanism of protection of rat spermatogenesis by hormonal pretreatment: stimulation of spermatogonial differentiation after irradiation. J Androl 2000;21:464-469.
61. Zhang Z, Shao S, Meistrich ML: The radiation-induced block in spermatogonial differentiation is due to damage to the somatic environment, not the germ cells. J Cell Physiol 2007;211:149-158.
62. Boekelheide K, Schoenfeld HA, Hall SJ, et al: Gonadotropin-releasing hormone antagonist (Cetrorelix) therapy fails to protect nonhuman primates (Macaca arctoides) from radiation-induced spermatogenic failure. J Androl 2005;26: 222-234.
63. Kamischke A, Kuhlmann M, Weinbauer GF, et al: Gonadal protection from radiation by GnRH antagonist or recombinant human FSH: a controlled trial in a male nonhuman primate (Macaca fascicularis). J Endocrinol 2003;179:183- 194.
64. Brinster RL, Avarbock MR: Germline transmission of donor haplotype following spermatogo-nial transplantation. Proc Natl Acad Sci USA 1994;91:11303-11307.
65. Clouthier DE, Avarbock MR, Maika SD, Hammer RE, Brinster RL: Rat spermatogenesis in mouse testis. Nature 1996;381:418-421.
66. Ogawa T, Dobrinski I, Avarbock MR, Brinster RL: Xenogeneic spermatogenesis following transplantation of hamster germ cells to mouse testes. Biol Reprod 1999;60:515-521.
67. Dobrinski I, Avarbock MR, Brinster RL: Germ cell transplantation from large domestic animals into mouse testes. Mol Reprod Dev 2000;57:270- 279.
68. Nagano M, McCarrey JR, Brinster RL: Primate spermatogonial stem cells colonize mouse testes. Biol Reprod 2001;64:1409-1416.
69. Reis MM, Tsai MC, Schlegel PN, et al: Xenogeneic transplantation of human spermatogonia. Zygote 2000;8:97-105.
70. Nagano M, Patrizio P, Brinster RL: Long-term survival of human spermatogonial stem cells in mouse testes. Fertil Steril 2002;78:1225-1233.
71. Sofikitis N: Transplantation of human spermato-gonia into the seminiferous tubules (STs) of animal testicles results in the completion of the human meiosis and the generation of human motile spermatozoa. Fertil Steril 1999;72(suppl 1): S83-S84.
72. Brannan CI, Bedell MA, Resnick JL, et al: Developmental abnormalities in Steel17H mice result from a splicing defect in the steel factor cytoplas-mic tail. Genes Dev 1992;6:1832-1842.
73. Ohta H, Yomogida K, Dohmae K, Nishimune Y: Regulation of proliferation and differentiation in spermatogonial stem cells: the role of c-kit and its ligand SCF. Development 2000;127:2125-2131.
74. Radford J, Shalet S, Lieberman B: Fertility after treatment for cancer. Questions remain over ways of preserving ovarian and testicular tissue. BMJ 1999;319:935-936.
75. Jahnukainen K, Hou M, Petersen C, Setchell B, Soder O: Intratesticular transplantation of testic-ular cells from leukemic rats causes transmission of leukemia. Cancer Res 2001;61:706-710.
76. Tegelenbosch RA, de Rooij DG: A quantitative study of spermatogonial multiplication and stem cell renewal in the C3H/101 F1 hybrid mouse. Mutat Res 1993;290:193-200.
77. Shinohara T, Orwig KE, Avarbock MR, Brinster RL: Spermatogonial stem cell enrichment by multiparameter selection of mouse testis cells. Proc Natl Acad Sci USA 2000;97:8346-8351.
78. Lue Y, Erkkila K, Liu PY, et al: Fate of bone marrow stem cells transplanted into the testis: potential implication for men with testicular failure. Am J Pathol 2007;170:899-908.
79. Honaramooz A, Li MW, Penedo MC, Meyers S, Dobrinski I: Accelerated maturation of primate testis by xenografting into mice. Biol Reprod 2004;70:1500-1503.
80. Geens M, De Block G, Goossens E, Frederickx V, Van Steirteghem A, Tournaye H: Spermatogonial survival after grafting human testicular tissue to immunodeficient mice. Hum Reprod 2006;21: 390-396.
81. Schlatt S, Honaramooz A, Boiani M, Scholer HR, Dobrinski I: Progeny from sperm obtained after ectopic grafting of neonatal mouse testes. Biol Reprod 2003;68:2331-2335.
82. Rathi R, Honaramooz A, Zeng W, Turner R, Dobrinski I: Germ cell development in equine testis tissue xenografted into mice. Reproduction 2006;131:1091-1098.
83. Schlatt S, Kim SS, Gosden R: Spermatogenesis and steroidogenesis in mouse, hamster and monkey testicular tissue after cryopreservation and heterotopic grafting to castrated hosts. Reproduction 2002;124:339-346.
84. Gromoll J, Eiholzer U, Nieschlag E, Simoni M: Male hypogonadism caused by homozygous deletion of exon 10 of the luteinizing hormone (LH) receptor: differential action of human chorionic gonadotropin and LH. J Clin Endocrinol Metab 2000;85:2281-2286.
85. Wistuba J, Mundry M, Luetjens CM, Schlatt S: Cografting of hamster (Phodopus sungorus) and marmoset (Callithrix jacchus) testicular tissues into nude mice does not overcome blockade of early spermatogenic differentiation in primate grafts. Biol Reprod 2004;71:2087-2091.
86. Wistuba J, Luetjens CM, Wesselmann R, Nieschlag E, Simoni M, Schlatt S: Meiosis in autologous ectopic transplants of immature testicular tissue grafted to Callithrix jacchus. Biol Reprod 2006;74:706-713.
87. Povlsen CO, Skakkebaek NE, Rygaard J, Jensen G: Heterotransplantation of human foetal organs to the mouse mutant nude. Nature 1974;248:247- 249.
88. Yu J, Cai ZM, Wan HJ, et al: Development of neonatal mouse and fetal human testicular tissue as ectopic grafts in immunodeficient mice. Asian J Androl 2006;8:393-403.
89. Schlatt S, Honaramooz A, Ehmcke J, et al: Limited survival of adult human testicular tissue as ectopic xenograft. Hum Reprod 2006;21:384- 389.
90. Wyns C, Curaba M, Martinez-Madrid B, Van Langendonckt A, Francois-Xavier W, Donnez J: Spermatogonial survival after cryopreservation and short-term orthotopic immature human cryptorchid testicular tissue grafting to immunodeficient mice. Hum Reprod 2007;22:1603-1611.
91. Tesarik J, Bahceci M, Ozcan C, Greco E, Mendoza C: Restoration of fertility by in-vitro spermatogenesis. Lancet 1999;353:555-556.
92. Lee DR, Kim KS, Yang YH, et al: Isolation of male germ stem cell-like cells from testicular tissue of non-obstructive azoospermic patients and differentiation into haploid male germ cells in vitro. Hum Reprod 2006;21:471-476.
93. Honaramooz A, Snedaker A, Boiani M, Scholer H, Dobrinski I, Schlatt S: Sperm from neonatal mammalian testes grafted in mice. Nature 2002; 418:778-781.
94. Jahnukainen K, Ehmcke J, Hergenrother SD, Schlatt S: Effect of cold storage and cryopreservation of immature non-human primate testicular tissue on spermatogonial stem cell potential in xenografts. Hum Reprod 2007;22:1060-1067.
95. Hovatta O, Foudila T, Siegberg R, Johansson K, von Smitten K, Reima I: Pregnancy resulting from intracytoplasmic injection of spermatozoa from a frozen-thawed testicular biopsy specimen. Hum Reprod 1996;11:2472-2473.
96. Tesarik J, Mendoza C: Using the male gamete for assisted reproduction: past, present, and future. J Androl 2003;24:317-328.
97. Sofikitis N, Mantzavinos T, Loutradis D, Yama-moto Y, Tarlatzis V, Miyagawa I: Ooplasmic injections of secondary spermatocytes for nonobstructive azoospermia. Lancet 1998;351: 1177- 1178.
98. Fujita K, Ohta H, Tsujimura A, et al: Transplantation of spermatogonial stem cells isolated from leukemic mice restores fertility without inducing leukemia. J Clin Invest 2005;115:1855-1861.
99. Tournaye H, Goossens E, Verheyen G, et al: Preserving the reproductive potential of men and boys with cancer: current concepts and future prospects. Hum Reprod Update 2004;10:525- 532.
100. Mau Kai C, Main KM, Andersen AN, Loft A, Skakkebaek NE, Juul A: Reduced serum testosterone levels in infant boys conceived by intracytoplasmic sperm injection. J Clin Endocrinol Metab 2007;92:2598-2603.